The use of angiotensin converting enzyme inhibitors (ACEIs) have been shown to be of no benefit in regard to exercise performance post Fontan (Kouatli et al. 1997). Moreover, in a recent Pediatric Heart Network study, the use of ACEIs before cavopulmonary connection surgery found no difference in somatic growth and did not impact the ventricular performance (Hsu & Pearson 2009b). Likewise, B-blockade agents specifically Carvedilol failed to significantly improve heart failure symptoms and even may be unfavorable to single right ventricular morphology (Shaddy et al.
The use of angiotensin converting enzyme inhibitors (ACEIs) have been shown to be of no benefit in regard to exercise performance post Fontan (Kouatli et al. 1997). Moreover, in a recent Pediatric Heart Network study, the use of ACEIs before cavopulmonary connection surgery found no difference in somatic growth and did not impact the ventricular performance (Hsu & Pearson 2009b). Likewise, B-blockade agents specifically Carvedilol failed to significantly improve heart failure symptoms and even may be unfavorable to single right ventricular morphology (Shaddy et al.